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Objective. To explore the relevance of cerebrospinal fluid to serum glu-
cose ratio in non-hypoglycorrhachic conditions.
Design. Retrospective observational study.
Setting. Neurology ward, university teaching hospital, Hong Kong.
Patients. Adult patients with conditions unrelated to hypoglycorrhachia
who underwent lumbar puncture.
Main outcome measures. Cerebrospinal fluid and simultaneous serum
glucose concentrations, and their ratio to each other.
Results. Between September 1998 and August 2003, 170 cerebrospinal
fluid and serum glucose samples were collected from 138 patients. Mean
cerebrospinal fluid to serum glucose ratio was 0.61 (standard deviation,
0.142; range, 0.21-1.00). With the exception of cerebrospinal fluid protein
level, laboratory parameters were similar among different diseases. The
glucose ratio was lower than 0.6 in 43% and lower than 0.5 in 19% of
samples. Cases with a low glucose ratio appeared to have higher serum
glucose concentrations (significant among groups with different glucose
ratios, P<0.001). The mean glucose ratio (0.65) was also significantly
higher in patients with serum glucose concentration of lower than
7.8 mmol/L compared with those with serum glucose concentration
between 7.8 and 11.1 mmol/L (mean, 0.46), or higher than 11.1 mmol/L
(mean, 0.46) [P<0.001]. There was a strong negative correlation between
the glucose ratio and serum glucose concentration (r= –0.704, P<0.001).
Conclusion. A lowered cerebrospinal fluid to serum glucose ratio is
often seen in the absence of an appropriate disorder, especially when
simultaneous serum glucose concentration is elevated. This may be
explained by the saturation kinetics of glucose transportation in
hyperglycaemia, and the time lag for cerebrospinal fluid and glucose to
equilibrate when the blood level fluctuates.
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Introduction
Lumbar puncture (LP) is an important and frequently
performed procedure. The nature of an underlying path-
ology is often reflected by changes in cerebrospinal
fluid (CSF) constituents. Low glucose concentration,
or hypoglycorrhachia, indicates the presence of dif-
fuse meningeal disorders, such as bacterial, fungal, or
tuberculous infection, leptomeningeal carcinomatosis,
other aseptic meningitides, and subarachnoid
haemorrhage.1-3 Most of these conditions are life-
threatening and must be promptly diagnosed and
treated. Normal CSF glucose concentration ranges
from 2.5 to 4.5 mmol/L.1
There is a dynamic equilibrium between blood and
CSF glucose levels; fluctuations in blood glucose
parallel changes in the CSF.1,4 Hypoglycorrhachia can
be masked by hyperglycaemia, and lowered CSF
glucose during hypoglycaemia may be misinterpreted
as meningitis. This misleading effect can be corrected
by estimating the CSF to blood glucose ratio, which
derives a fairly constant value. The widely accepted
normal ratio is between 0.6 and 0.8, although
0.5 has also been considered the lower limit of
normal.1-3,5-7 Less than this level indicates pathologi-
cal hypoglycorrhachia.
The concept of a ‘normal’ ratio had been challenged
as an over-simplification of the relationship between
CSF and serum glucose at different concentrations.8,9
A study of 79 men with no CSF abnormalities and
the published data from about 100 normal subjects
revealed that the CSF to blood glucose ratio was not a
valid measure of their true relationship.9 In addition,
previous reports often focused on healthy subjects or
excluded those with abnormal CSF findings. This study
aimed to explore the relevance of CSF to serum glucose
ratio in patients with neurological disorders.
Methods
The admission and follow-up records of patients who
had CSF collected under the care of the neurology ward
between September 1998 and August 2003 were retro-
spectively reviewed. Only LP samples were studied.
Patients diagnosed with conditions associated with
CSF hypoglycorrhachia and patients whose CSF white
cell count exceeded 20 x 106 /L were excluded. Simul-
taneous serum glucose was defined as the glucose
concentration in blood taken within 1 hour of LP
(before or after). Patients in whom a simultaneous
serum glucose level was unavailable were also
excluded. Blood samples were transported to the labo-
ratory in standard fluoride/oxalate tubes. Glucose
concentrations were measured by the hexokinase
method on a Hitachi 747 analyser (Boehringer
Mannheim, Mannheim, Germany). Fasting before
LP was not mandatory. None of the patients had
received concentrated intravenous glucose solution
within 4 hours of LP, but infusion of glucose solution
of 5% or lower was permitted as this would not
affect the equilibrium between CSF and glucose
levels.8 Diagnosis, CSF findings (protein and glucose
concentrations, white cell count), simultaneous serum
glucose concentrations, and CSF to serum glucose
ratios were recorded for each set of samples.
All statistical analyses were performed using the
Statistical Package for the Social Sciences (Windows
version 12.0; SPSS Inc, Chicago [IL], US). For group
comparisons, depending on homogeneity of variance,
independent-samples t test, one-way analysis of
variance, or Kruskal-Wallis test (H-test) was applied.
The relationship between CSF to serum glucose ratio
and serum glucose concentration was tested with
Spearman’s rank order correlation coefficient.
Results
One hundred and seventy sets of samples from 138
patients were studied (22 patients underwent more than
one LP). The mean age of patients was 51.4 years
(range, 19-86 years). The final diagnoses are shown in
Table 1. Follow-up records for at least 1 year after LP
were available in 135 patients. The remaining three
patients had died—a 70-year-old man with peripheral
neuropathy died of a ruptured aortic aneurysm; an-
other patient diagnosed to have transverse myelitis died
of pneumonia; the last patient had Lambert-Eaton syn-
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drome and carcinoma of the lung. No brain metastasis
was found on magnetic resonance imaging at the time of
LP. Cytological examinations of CSF were also negative.
The overall mean CSF to serum glucose ratio was
0.61 (standard deviation, 0.142; range, 0.21-1.00), with
a mean CSF glucose concentration of 3.89 mmol/L
(range, 2.1-11.8 mmol/L) and simultaneous serum
glucose concentration of 6.78 mmol/L (range, 3.4-
27.6 mmol/L). Mean CSF protein level was 0.85 g/L
(range, 0.13-4.74 g/L) and white cell count was
2.29 x 106 /L (range, 0-18 x 106 /L). The CSF glucose
concentration was lower than 2.5 mmol/L in two
samples: one patient with transverse myelitis had an
initial CSF glucose concentration of 2.1 mmol/L but
was normal on repeated LP. No infection or malig-
nancy was identified. Another patient had associated
hypoglycaemia whose CSF glucose concentration was
2.3 mmol/L and serum level was 3.4 mmol/L.
There were no significant differences among the
nine disease groups in CSF to serum glucose ratio, CSF
glucose concentration, serum glucose concentration,
or CSF white cell count. The CSF protein level
appeared higher in patients with demyelinating or
inflammatory conditions (H-test, P<0.05).
Table 2 shows the number of samples with different
CSF to serum glucose ratios. The ratio was lower
than 0.6 in 43% and lower than 0.5 in 19% of samples.
Serum glucose concentration was significantly differ-
ent among the five groups (H-test, P<0.001): the
concentration was highest for samples with a ratio of
lower than 0.4 and it decreased as the ratio increased.
Mean CSF glucose for each group ranged from 3.55
to 4.51 mmol/L. Although the difference was statisti-
cally significant (H-test, P<0.05), a trend similar to
that of serum glucose concentration was not found.
The means of age (H-test, P=0.117), CSF protein level,
and white cell count were not significantly different
among the five groups.
Thirty sets of samples were from patients with
diabetes mellitus: two controlled by diet alone, 16 on
oral hypoglycaemic agents, and 12 on insulin. Their
mean serum glucose concentration was 11.03 mmol/L
(range, 5.8-27.6 mmol/L), compared with 5.88 mmol/L
(range, 3.4-11.8 mmol/L) in non-diabetic patients (t
test, P<0.001). The differences in CSF to serum glu-
cose ratio and CSF glucose concentration were sig-
nificant between the  two groups (t test, P<0.05 and
<0.001, respectively). The mean glucose ratio in sam-
ples with simultaneous serum glucose concentration of
lower than 7.8 mmol/L was 0.65 (range, 0.44-1.00;
n=132). In samples with serum glucose concentration
of 7.8 to 11.1 mmol/L, the mean ratio was 0.46 (range,
0.21-0.74; n=25). In samples with serum glucose con-
centration of higher than 11.1 mmol/L, the mean ratio
was also 0.46 (range, 0.32-0.75; n=13). The difference
among the three mean ratios was significant (H-test,
P<0.001). Respectively to the three groups of samples,
the glucose ratio were lower than 0.6 in 31%, 84%,
Table 1.  Final diagnoses and related laboratory values
Diagnosis No. of Mean values
samples, CSF* Serum CSF to serum CSF CSF white
n=170 glucose glucose glucose protein† cell count
(mmol/L) (mmol/L) ratio (g/L) (x 106 /L)
Peripheral or cranial neuropathies 64 4.11 17.45 0.59 0.96 2.13
Demyelination or non-infective 45 3.57 16.11 0.61 1.11 3.38
inflammation of brain and spinal
cord (eg multiple sclerosis, optic
neuritis)
Headaches 26 3.87 16.60 0.61 0.46 1.38
Normal pressure hydrocephalus 11 4.17 16.57 0.67 0.53 1.27
Workup for neurodegenerative 28 3.81 15.58 0.72 0.46 1.00
diseases
Stroke 25 4.48 10.46 0.49 0.68 5.20
Seizure 23 3.27 16.20 0.54 0.58 2.00
Others: Lambert-Eaton myasthenia 24 3.60 15.33 0.68 0.94 2.50
syndrome (n=2), cervical
myelopathy (n=1), Tolosa-Hunt
syndrome (n=1)
Unclassified or psychosomatic 24 3.65 15.13 0.71 0.65 2.29
disorders
* CSF cerebrospinal fluid
† Significantly different (Kruskal-Wallis H-test, P<0.05)
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and 85%, and lower than 0.5 in 7%, 60%, and 69%
(Chi squared test, P<0.001 for both ratios).
The CSF to serum glucose ratio was plotted against
the simultaneous serum glucose concentration (Fig).
The ratio did not remain constant but showed a
strong negative correlation (r= –0.704, P<0.001),
which remained significant after excluding the outliers
(r= –0.665, P<0.001).
Discussion
The CSF to serum glucose ratio is conventionally used
to adjust CSF glucose concentration for blood glucose
concentration at different glycaemic levels. Previous
studies focused on patients without CSF abnormalities
or with specific disorders.8,9 This study included
patients with a spectrum of commonly encountered
neurological conditions. Many patients had a ratio
below the normal range (ie <0.6 or <0.5). Their
diagnoses and records were reviewed carefully, and
none of them had any condition associated with
hypoglycorrhachia. A significant negative correlation
was also found between serum glucose concentration
and the CSF to serum glucose ratio.
In meningitis, CSF glucose is depressed by
pathogens as well as anaerobic glycolysis in adjacent
neural tissue.1 Glucose is also consumed by neutrophils
although to a lesser extent; in order to minimise such
effect in this study, case inclusion was arbitrarily cut-
off at a CSF white cell count of 20 x 106 /L. Although
this did not exclude all samples with pleocytosis, pa-
tients with low glucose ratios did not have more
leukocytes than those with higher ratios.
Abnormal glycolysis generates lactate.3 Measure-
ment of CSF lactate level, though not performed rou-
tinely in this study, may distinguish a false low CSF to
serum glucose ratio from pathological glucose
consumption. Nevertheless, elevated lactate level is not
specific for meningitis; lactate also accumulates in the
CSF in the presence of many other neurological and
systemic diseases, including stroke, epilepsy, multiple
sclerosis, cervical spondylosis, pneumonia, heart
failure, uraemia, and hepatic failure.4
Concentration of glucose in CSF is mainly regulated
by the choroid plexus through facilitated transportation
that exhibits saturable kinetics.10-13 Animal data reveal
that the rate of glucose extraction increases steadily
with rising blood glucose concentration.11,12 In cats,
when blood glucose concentration is beyond
11.1 mmol/L, the extraction rate will gradually pla-
teau until it is saturated.12 This dissociated increment
was illustrated in the present study by lowering of
CSF to serum glucose ratio at hyperglycaemia,
although the scatterplot (Fig) failed to match a logis-
tic regression curve expected from the saturation
kinetics of glucose transportation. Conversely, a
reduced glucose ratio was also present in some
normoglycaemic patients. When the serum glucose
level fluctuates rapidly, there is a delay of 1 to 2 hours
before a steady state can be re-established in the
CSF because of its slow turnover rate.8 In this situation,
a low glucose ratio may reflect inadequate CSF
responsiveness to an upsurge in blood glucose from
procedure-related stress.14
A previous group devised a linear regression
normogram for ascertaining hypoglycorrhachia at vari-
ous glycaemic levels (though the model could not ad-
dress the deviation from linearity at high serum
concentrations when glucose transportation saturates),
and calculated that a CSF to serum glucose ratio of
0.6 or 0.5 could no longer be assumed when blood
Table 2.  Number and cumulative percentage of samples with different cerebrospinal fluid (CSF) to serum
glucose ratios, and comparisons of serum and CSF glucose concentrations, CSF protein level, and white cell
count among groups with different ratios
CSF to serum No. of Cumulative Mean values
glucose ratio samples, percent Serum glucose* CSF glucose† CSF protein‡ CSF white cell
n=170 (mmol/L) (mmol/L) (g/L) count§ (x 106 /L)
<0.40 11 007 11.06 3.55 0.97 1.18
0.40-0.49 22 019 10.16 4.51 0.90 2.50
0.50-0.59 40 043 16.77 3.71 0.91 2.73
0.60-0.69 52 074 15.78 3.67 0.94 2.83
≥0.70 45 100 15.27 4.10 0.64 1.44
* Significantly different (Kruskal-Wallis H-test, P<0.001)
† Significantly different (Kruskal-Wallis H-test, P<0.05)
‡ Not significant (One-way ANOVA, F=1.086; P=0.365)
§ Not significant (Kruskal-Wallis H-test, P=0.187)
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glucose concentration exceeded 6.9 or 10.6 mmol/L,
respectively.9 In the present study, glucose ratios were
significantly lower, and more cases had ratios below
0.6 or 0.5 when random glucose was between 7.8 and
11.1 mmol/L or higher than 11.1 mmol/L, respectively.
The latter is diagnostic of diabetes mellitus and the
former indicates impaired glucose tolerance that is
associated with stress-induced hyperglycaemia.15,16
One potential source of error in this study was the
difficulty in controlling the time between blood
sampling and determination of serum glucose
concentration. Because of transportation and
laboratory handling, some delay in separation of
serum from red cells was inevitable. It is also
well-known that glycolysis prior to separation cannot
be completely inhibited by the standard fluoride/
oxalate preservatives.17 Simultaneous serum
glucose levels in the specimens may thus have
been underestimated (ie CSF to serum glucose
ratio would be overestimated). Nevertheless, if the
samples were tested within a few hours, a major
reduction in serum glucose concentration should
not be expected. More importantly, these data reflect
the actual situation in clinical practice and patient
management.
Conclusion
A reduced CSF to serum glucose ratio was often seen
in the absence of an appropriate neurological disorder.
This is contrary to the conventional belief. The ratio
may be unreliable even with modest elevations of si-
multaneous serum glucose level during LP. An isolated,
clinically unexplained lowering of CSF to serum glu-
cose ratio should therefore be interpreted with caution
and not be overstated.
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